Gunnar Olof Olsson

Gunnar Olof Olsson is Vice Chairman at Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt, Chairman at Betagenon Sweden AB since 2021, Chairman at Betagenon Bio AB, Vice Chairman at the University of Lund, Director at BioCrine AB, Director at IRLAB Therapeutics AB since 2017, Director at Gesynta Pharma AB, Director at Olsson Solutions AB, Director at Amplifier TX AB, Independent Director at Cereno Scientific AB since 2024, and Principal at Olsson Solutions Kommanditbolag.
Former roles include Chairman at Athera Biotechnologies AB, Director at The European Society of Cardiology, and Manager-Global Cardiovascular at AstraZeneca AB. Education includes a doctorate from Karolinska Institutet and undergraduate studies at the International Institute for Management Development.